Michael J. Rossi - 07 Mar 2025 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Signature
/s/ John LaRocca, Attorney-in-Fact
Issuer symbol
YMAB
Transactions as of
07 Mar 2025
Transactions value $
-$20,368
Form type
4
Filing time
11 Mar 2025, 20:17:08 UTC
Previous filing
22 Jan 2025
Next filing
18 Sep 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$20,368 -3,917 -2.8% $5.2 137,083 07 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.